| Literature DB >> 24626555 |
Raquel da Rocha Paiva Maia, Victor Wünsch Filho.
Abstract
OBJECTIVE: To analyze studies that evaluated the role of infections as well as indirect measures of exposure to infection in the risk of childhood leukemia, particularly acute lymphoblastic leukemia.Entities:
Mesh:
Year: 2013 PMID: 24626555 PMCID: PMC4206105 DOI: 10.1590/s0034-8910.2013047004753
Source DB: PubMed Journal: Rev Saude Publica ISSN: 0034-8910 Impact factor: 2.106
Review of studies on maternal infection and risk of childhood leukemia, 1973-2011.
| Reference | Place | Study design | Infectious agent or disease | Disease | Risk (95%CI) | |
|---|---|---|---|---|---|---|
| Increased risk | ||||||
| Hakulinen et al[ | Finland | BC | Asian influenza | CL | Exposed incidence: 68.1/million | |
| Unexposed incidence: 4.2/million; P = 0.048 | ||||||
| Austin et al[ | Los Angeles | BC | Influenza | CL | RR 3.4 | |
| Vianna & Polan[ | USA | ECO | Chicken pox | CL | Expected incidence < 1 | |
| Observed incidence = 3 | ||||||
| Till et al[ | England | CC | Varicella and herpes zoster | ALL | Number cases higher than expected (2 of 54) | |
| Mckinney et al[ | IREESC | CC | Skin disease | CL | RR 2.3 (1.1;4.7) | |
| Buckley et al[ | USA Canada | CC | Any maternal infection | ALL | OR 1.5 (p < 0.05) | |
| Naumburg et al[ | Sweden | CC | Lower genital tract infection | ALL | OR 1.63 (1.04;2.53) | |
| CL | OR 1.78 (1.17;2.72) | |||||
| Lehtinen et al[ | Finland Iceland | CC | ALL | OR 2.9 (1.5;5,8) | ||
| Lehtinen et al[ | Finland Iceland | CC | Helicobacter pylori | CL | OR 2.8 (1.1;6.9) | |
| Kwan et al[ | California | CC | Influenza/pneumonia | ALL | OR 1.89 (1.24;2.89) | |
| CL | OR 1.74 (1.18;2.57) | |||||
| Sexually transmitted diseases | ALL | OR 4.85 (1.24;18.96) | ||||
| CL | OR 6.33 (1.65;24.27) | |||||
| Tedeschi et al[ | Finland Iceland | CC | ALL | OR 1.9 (1.2;3.0) | ||
| Non-significant effect or no association | ||||||
| Randolph & Heath[ | USA | BC | Influenza | CL | No consistent increased incidence | |
| Curnen et al[ | Connecticut | ECO | Influenza, chickenpox, whooping… | CL | No significant positive correlations | |
| Dockerty et al[ | New Zealand | CC | Influenza | CL | OR 0.58 (0.24;1.41) | |
| Cold sores/oral herpes | OR 0.70 (0.25;1.99) | |||||
| Mckinney et al[ | Scotland | CC | Respiratory tract | ALL | OR 1.64 (0.60;4.46) | |
| Genitourinary | OR 1.18 (0.50;2.79) | |||||
| Infante-Rivard et al[ | Quebec | CC | Recurrent infections | ALL | OR 1.09 (0.65;1.84) | |
BC: Birth cohort study; CC: Case-control study; ECO: Ecological study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; RR: Relative risk
Review of studies on childhood infection and risk of leukemia, 1973-2011.
| Reference | Place | Study design | Infectious agent or disease | Disease | Risk (95%CI) | |
|---|---|---|---|---|---|---|
| Infection in the first 2 years of life: protective effect | ||||||
| Dockerty et al[ | New Zealand | CC | Eye infection | ALL | OR 0.2 (0.1;0.7) | |
| Mckinney et al[ | Scotland | CC | Skin infection | ALL | OR 0.2 (0.05;0.87) | |
| CL | OR 0.2 (0.05;0.87) | |||||
| Neglia et al[ | USA | CC | Ear infection | ALL | Ear infection episodes reduced the risk: p trend = 0.026 | |
| Chan et al[ | Hong Kong | CC | Roseola and/or fever + rash | ALL | OR 0.33 (0.16;0.68) | |
| Perrilat et al[ | France | CC | Surgical procedures: ear, nose, throat | CL | OR 0.4 (0.2;0.9) | |
| Jourdan-da Silva et al[ | France | CC | ≥4 gastrointestinal infections | ALL | OR 0.1 (0.03;0.6) | |
| Rosembaum et al[ | New York State | CC | Diarrhoea | ALL | OR 0.69 (0.48;0.99) | |
| Simpson et al[ | UK | CC | Eye infection | ALL | OR 0.7 (0.5;0.9) | |
| Rudant et al[ | France | CC | Otitis; Bronchiolitis/other lower respiratory tract infections; Gastroenteritis | ALL | OR 0.7 (0.5;1.0) | |
| OR 0.3 (0.2;0.6) | ||||||
| OR 0.3 (0.1;0.8) | ||||||
| Urayama et al[ | California | CC | Ear infection: non-Hispanic children; Hispanic children | ALL | OR 0.39 (0.17;0.91) | |
| OR 0.48 (0.27;0.83) | ||||||
| Infection in the first 2 years of life: increased risk | ||||||
| Dockerty et al[ | New Zealand | CC | Influenza | CL | OR 6.80 (1.81;25.66) | |
| ALL | OR 6.0 (1.4;26.2) | |||||
| Perrilat et al[ | France | CC | Mumps | CL | OR 3.2 (1.1;9.0) | |
| Rosembaum et al[ | New York State | CC | Otitis in the second year of life | ALL B lineage | OR 1.56 (1.02;2.37) | |
| Roman et al[ | UK | CC | Upper respiratory tract infection Fungal infection | ALL | OR 1.3 (1.0;1.7) | |
| OR 1.9 (1.1;3.2) | ||||||
| Simpson et al[ | UK | CC | At least one infection | ALL | OR 1.6 (1.1;2.2) | |
| Cardwell et al[ | UK | CC | Upper respiratory tract infections; Chickenpox | ALL | OR 1.59 (1.02;2.49) | |
| OR 2.62 (1.12;6.13) | ||||||
| Rudant et al[ | France | CC | Upper respiratory tract infections | ALL | OR 1.6 (1.3;2.0) | |
| Infection in the first 2 years of life: non-significant effects or no association | ||||||
| Van Steensel-Moll et al[ | Netherlands | CC | Common colds; Fever | ALL | RR 0.8; p > 0.05; RR 0.9; p > 0.05 | |
| Naumburg et al[ | Sweden | CC | History of infection in the postpartum | CL | OR 1.0 (0.50;2.04) | |
| Infection at any time prior to the diagnosis: protective effect | ||||||
| Schlehofer et al[ | Germany | CC | Herpes labialis | CL | RR 0.38 (0.15;0.96) | |
| Schuz et al[ | Germany | CC | Chickenpox | AL | OR 0.8 (0.7;1.0) | |
| Ma et al[ | California | CC | Ear infection (in non-Hispanic) | c-ALL | OR 0.32 (0.14;0.74) | |
| Infection at any time prior to the diagnosis: increased risk | ||||||
| Mckinney et al[ | UK | CC | Number of illness episodes | CL | RR 1.9 (1.0;3.4) | |
| Jourdan-da Silva et al[ | France | CC | Rubella | ALL | OR 2.4 (1.4;4.1) | |
| Infection at any time prior to the diagnosis: non-significant effect or no association | ||||||
| Macarthur et al[ | Canada | CC | Mumps | ALL | OR 0.57 (0.13;2.52) | |
| Measles | OR 0.62 (0.25;1.27) | |||||
| Infection at diagnosis or in the year before diagnosis: increased risk | ||||||
| Schuz et al[ | Germany | CC | Bronchitis | c-ALL | OR 1.9 (1.3;2.7) | |
| Pneumonia | OR 2.6 (1.4;4.8) | |||||
| Chan et al[ | Hong Kong | CC | Tonsillitis | c-ALL | OR 2.96 (1.32;6.66) | |
| Kroll et al[ | Britain | ECO | Influenza | c-ALL | Influenza epidemic preceded peak of c-ALL | |
| Infection at diagnosis or in the year before diagnosis: laboratory analysis | ||||||
| Schlehofer et al[ | Germany | CC | Epstein-Barr Virus | CL | RR 2.05 (0.99;4.23) | |
| Parvovirus B-19 | RR 0.48 (0.14;1.69) | |||||
| Adeno-associated virus type 2 | RR 0.66 (0.29;1.50) | |||||
| Human herpes virus type 6. | RR 1.11 (0.54;2.28) | |||||
| Petridou et al[ | Greece | CC | Epstein-Barr virus | ALL | OR 0.4 (0.2;0.8) | |
| Human herpes virus type 6 | OR 0.5 (0.3;0.9) | |||||
| Mycoplasma | OR 0.1 (0.0;0.7) | |||||
| Parainfluenza1,2,3 | OR 1.9 (1.1;3.2) | |||||
| Mahjour et al[ | Iran | CC | Herpes Simplex Viruses 1 and 2; | ALL | The prevalence of antibodies against HBsAg (p = 0.002), HSV1 (p < 0.0001), VCA (p = 0.021) and EA (p < 0.0001) antigens of EBV were higher in ALL patients. | |
| Epstein-Barr Virus; | ||||||
| hepatitis B Virus | ||||||
| Sehgal et al[ | India | CC | Epstein Barr Virus | ALL | Significant increase in EBV in ALL patients (p < 0.05) | |
CC: Case-control study; ECO: Ecological study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; AL: Acute leukemia; c-ALL: B-cell precursor common AL; RR: Relative risk; OR: Odds ratio; 95%CI: 95% confidence interval
Study listed more than once in the table
Review of studies on daycare attendance and risk of childhood
| Reference | Place | Study design | Disease | Variables | Risk (95%CI) | |
|---|---|---|---|---|---|---|
| Protective effect | ||||||
| Petridou et al[ | Attica (Greece) | CC | CL | Attendance at day-care for > 3 months in the first two years of life | OR 0.28 (0.09;0.88) | |
| Infante-Rivard et al[ | Quebec | CC | ALL | Entry at ≤ 2 years old | OR 0.49 (0.31;0.77) | |
| Perrilat et al[ | France | CC | AL | Age at start of day care ≤ 6 months
| OR 0.5 (0.3;1.0) | |
| Ma et al[ | California | CC | ALL | Children who had more total child – hours of attendance at day-care | OR 0.64 (0.45;0.95) | |
| Jourdan-Da Silva et al[ | France | CC | ALL | Age at start of day-care < 3 months
| OR 0.6 (0.4;0.8) | |
| Ma et al[ | California | CC | ALL | Children (non-Hispanic white) who had more time of attendance at day-care | OR 0.42 (0.18;0.99) | |
| Gilham et al[ | UK | CC | ALL | Formal day care in the first year of life | OR 0.48 (0.37;0.62) | |
| Age at start of day-care < 3
months | OR 0.56 (0.37;0.83) | |||||
| Kamper-Jorgensen et al[ | Denmark | CC | ALL | Childcare in the first 2 years | OR 0.68 (0.48;0.95) | |
| Urayama[ | California | CC | ALL | Attendance day-care by age 6 months (non-Hispanic white) | OR 0.83 (0.73;0.94) | |
| Non-significant effect or no association | ||||||
| Roman et al[ | England | CC | ALL | Child's attendance at preschool playgroup | OR 0.6 (0.2;1.8) | |
| Petridou et al[ | Greece | CC | CL | Day-care: Yes | OR 0.83 (0.51;1.37) | |
| Schuz et al[ | Germany | CC | c-ALL | Deficit in social contact | OR 1.0 (0.8;1.2) | |
| Neglia et al[ | USA | CC | ALL | Age at start of day care < 6 months | OR 0.91 (0.72;1.15) | |
| Rosenbaum et al[ | New York State | CC | ALL | Duration of out-of-home care (months): stayed
home ( | OR 1.32 (0.70;2.52) | |
| Chan et al[ | Hong Kong | CC | c-ALL | Attendance at day-care during first year of life | OR 0.93 (0.63;1.36) | |
| Abdul Rahman et al[ | Malaysia | CC | AL | Attendance in day-care (Yes
| OR 1.12 (0.65;1.92) | |
| Rudant et al[ | France | CC | ALL | Full-time day-care attendance in the first year of life | OR 0.8 (0.6;1.1) | |
CC: Case-control study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; AL: Acute leukemia; c-ALL: B-cell precursor common ALL; OR: Odds ratio; 95%CI: 95% confidence interval
Review of studies on birth order and risk of childhood leukemia, 1973-2011.
| Reference | Place | Study design | Disease | Variables | Risk (95%CI) | |
|---|---|---|---|---|---|---|
| Negative association: protective effect associated with higher birth order/ increased risk associated with lower birth order | ||||||
| Van steensel-moll[ | Netherlands | CC | ALL | There were more first-born children in cases | RR 1.8 (1.1;2.7) | |
| Infante-Rivard et al[ | Quebec | CC | ALL | Having older siblings in the 1st year of life (in cases diagnosed at 4 years of age or later) | OR 0.46 (0.22;0.97) | |
| Petridou et al[ | Greece | CC | ALL | Birth order: other | OR 0.5 (0.3;0.9) | |
| Dockerty et al[ | England Wales | CC | ALL | Parity ≥ 5 | OR 0.52 (0.34;0.80) | |
| Rudant et al[ | France | CC | ALL | Parity ≥ 4 | OR 0.5 (0.3;0.8) | |
| Urayama[ | California | CC | ALL | Birth order ≥ 4 | OR 0.44 (0.21;0.92) | |
| Positive association: increased risk associated with higher birth order/ protective effect associated with lower birth order | ||||||
| Infante-Rivard et al[ | Quebec | CC | ALL | Having older siblings at time of diagnosis (in children diagnosed before 4 years of age) | OR 4.54 (2.27;9.07) | |
| Shu et al[ | USA | CC | ALL | Birth order ≥ 4 | OR 2.0 (1.3;3.0) | |
| Reynolds et al[ | California | CC | ALL | Number of previous live births ≥ 3
| OR 1.53 (1.00;2.34) | |
| Jourdan-Da Silva et al[ | France | CC | ALL | Birth order ≥ 4 | OR 2.0 (1.1;3.7) | |
| Abdul Rahman et al[ | Malaysia | CC | AL | Number of elder siblings < 2
| OR 0.37 (0.22;0.64) | |
| Non-significant effect or no association | ||||||
| Roman et al[ | England | CC | ALL | Number of siblings ≥ 2 | OR 0.8 (0.2;3.0) | |
| Westergaard et al[ | Denmark | COH | ALL | Birth order ≥ 4 | RR 0.72 (0.46;1.13) | |
| Petridou et al[ | Greece | CC | CL | Risk decreases with increasing birth order | OR 0.74 (0.48;1.15) | |
| Schuz et al[ | German | CC | c-ALL | First-born child (yes | OR 1.1 (1.0;1.4) | |
| Mckinney et al[ | Scotland | CC | ALL | Parity (0 | OR 0.81 (0.52;1.25) | |
| CL | OR 0.82 (0.55;1.23) | |||||
| Neglia et al[ | USA | CC | ALL | Number of older siblings ≥ 2
| OR 1.05 (0.88;1.26) | |
| Perrilat et al[ | France | CC | ALL | Birth order ≥ 4 | OR 1.4 (0.7;2.8) | |
| Murray et al[ | Ireland | COH | ALL | First-born | RR 0.98 (0.71;1.36) | |
| Okcu et al[ | Texas | CC | ALL | Parity ≥ 5 | OR 1.0 (0.1;7.8) | |
| CL | OR 0.5 (0.1;4.3) | |||||
| Gilham et al[ | UK | CC | ALL | Number of siblings ≥ 3 | OR 0.99 (0.74;1.30) | |
| Kamper-Jorgensen et al[ | Denmark | CC | ALL | Older siblings > 2 | RR 0.93 (0.72; 1.19) | |
CC: Case-control study; COH: Cohort study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; AL: Acute leukemia; c-ALL: B-cell precursor common ALL; RR: Relative risk; OR: Odds ratio; 95%CI: 95% confidence interval
Study listed more than once in the table
Review of studies on breastfeeding and risk of childhood leukemia, 1973-2011.
| Reference | Place or group | Study design | Disease | Time of breast feeding | Risk (95%CI) | |
|---|---|---|---|---|---|---|
| Negative association: protective effect associated with longer breastfeeding period/increased risk associated with shorter breastfeeding period | ||||||
| Dockerty et al[ | New Zealand | CC | ALL | > 1 year | OR 0.5 (p = 0.04) | |
| Shu et al[ | USA, Canada, Australia | CC | ALL | > 6 | OR 0.72 (0.60;0.87) | |
| More time breastfeeding | p trend = 0.0034 | |||||
| Infante-Rivard et al[ | Quebec | CC | ALL | >3 months | OR 0.67 (0.47;0.94) | |
| Bener et al[ | United Arab Emirates | CC | ALL | 0-6 months | OR 2.47 (1.17;5.25) | |
| Perrilat et al[ | France | CC | AL | ≥ 6 months | OR 0.5 (0.2;0.9) | |
| Bener et al[ | Qatar | CC | ALL | 0-6 months | Males: OR 3.1 (1.4;6.8) | |
| Females: OR 2.2 (0.8;6.32) | ||||||
| Rudant et al[ | France | CC | ALL | ≥ 6 months | OR 0.7 (0.5;1.0) | |
| Non-significant effect or no association | ||||||
| Petridou et al[ | Greece | CC | CL | yes | OR 0.85 (0.52;1.41) | |
| Schuz et al[ | Germany | CC | c-ALL | 2-6 months | OR 1.2 (0.9;1.6) | |
| UKCCS[ | UK | CC | ALL | ≥ 7 months | OR 0.89 (0.75;1.05) | |
| Murray et al[ | Ireland | COH | ALL | no | RR 0.98 (0.68;1.42) | |
| Chan et al[ | Hong Kong | CC | c-ALL | ≥ 6 months (yes | OR 0.21 (0.03;1.76) | |
| Lancashire & Sorahan[ | UK | CC | ALL | ever | OR 1.04 (0.86;1.26) | |
| CL | OR 1.05 (0.89 ;1.23) | |||||
| Jourdan-Da Silva et al[ | France | CC | ALL | yes | OR 1.1 (0.9;1.5) | |
| Kwan et al[ | California | CC | ALL | ever | OR 0.99 (0.64;1.55) | |
| Macarthur et al[ | Canada | CC | ALL | 7-12 months (yes | OR 1.02 (0.68;1.53) | |
| CL | OR 1.00 (0.67;1.50) | |||||
| Waly et al[ | Oman | CC | ALL | No statistically significant difference | χ2 = 3.816, P = 0.282 | |
CC: Case-control study; COH: Cohort study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; AL: Acute leukemia; c-ALL: B-cell precursor common ALL; RR: Risk relative; OR: Odds ratio; 95%CI: 95% confidence interval